>
The Secret Campaign To Stop RFK Jr.
You Can't Grow Your Way Out: The GOP's Debt Delusion Exposed
Musk Sets Off Fireworks: Polls X Users on End of Two-Party 'Uniparty' System...
xAI Grok 3.5 Renamed Grok 4 and Has Specialized Coding Model
AI goes full HAL: Blackmail, espionage, and murder to avoid shutdown
BREAKING UPDATE Neuralink and Optimus
1900 Scientists Say 'Climate Change Not Caused By CO2' – The Real Environment Movement...
New molecule could create stamp-sized drives with 100x more storage
DARPA fast tracks flight tests for new military drones
ChatGPT May Be Eroding Critical Thinking Skills, According to a New MIT Study
How China Won the Thorium Nuclear Energy Race
Sunlight-Powered Catalyst Supercharges Green Hydrogen Production by 800%
After the findings of the study were published, Australian Professor Ian Brighthope has classified the injections as class one carcinogens.
More than a year ago, Professor Dr. Angus Dalgleish, a renowned oncologist practising in the UK, first published his concerns that his patients with melanoma were relapsing after several years of being in remission.
"I could find none of the usual causes but on further investigation, I realised that they had all had a booster covid vaccine between three weeks and three months before their cancer's resurgence, the time in which their immune repression fails," he wrote in The Conservative Woman on Monday.
After raising the alarm that the vaccine boosters could induce cancer relapse, he became aware of literally dozens of people who had not had cancer before developing leukaemia and lymphomas after the boosters.
In November 2022, Prof. Dalgleish wrote an open letter to the editor-in-chief of the medical journal The BMJ, urging the journal that harmful effects of Covid injections be "aired and debated immediately" because cancers and other diseases are rapidly progressing among "boosted" people.
A few weeks later, he reported that other oncologists had contacted him to say they were seeing the same phenomenon of the recurrence of cancer in many melanoma patients who had been stable for long periods.